Clinical trial
Compassionate Use of Stiripentol in Intractable Epilepsy Due to Dravet Syndrome
NCT01533506 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compassionate Use of Stiripentol in Intractable Epilepsy Due to Dravet Syndrome
- Lead sponsor
- Mayo Clinic
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- February 29, 2012
- Completion date
- February 28, 2013
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dravet syndrome